Alopecia preclinical models / Pathology background / Clinical views
Alopecia preclinical models are necessary in R&D.
The medical term for the loss of hair on the head or body is alopecia.
Alopecia can take many different forms, but the most prevalent ones are alopecia areata and androgenic alopecia.
Alopecia is not a fatal condition, but it can have a significant psychological impact on those who have it and change their lives.
In androgenetic (or pattern) alopecia, terminal hairs gradually turn into indeterminate and then vellus hairs, a genetically determined condition. The illness is quite widespread and can afflict both men and women.
Alopecia preclinical models were developed as models of alopecia androgenetic or areata.
In clinical oncology, chemotherapy-induced alopecia (ChIA) is still an open issue. Psycho-social stress is brought on by hair loss, and some patients will even decline treatment out of concern for their hair.
Regrowth can be seen 3–6 months after chemotherapy ends, and ChIA is typically reversible. However, there have been more and more reports of permanent ChIA, which is defined as no hair growth after six months of stopping chemotherapy. The underlying patho-physiology, particularly for permanent ChIA, remains insufficiently understood and is associated with a lack of effective preventive treatment.
Alopecia preclinical models were developed at Imavita for R&D purpose.
Models Overview
Alopecia aerata / Androgenetic alopecia / Hair regrowth model
Alopecia preclinical models
Simple hair regrowth model on aged animals and/or shaving induction
Please inquire for more details
Chemotherapy induced alopecia model
Alopecia preclinical models
Hair regrowth model after chemotherapy (cyclophosphamide) alopecia induction
Please inquire for more details
Please inquire for more details on Alopecia preclinical models